CBI INDUSTRIES INC /DE/
SC 14D9/A, 1995-12-08
INDUSTRIAL INORGANIC CHEMICALS
Previous: CBI INDUSTRIES INC /DE/, SC 14D1/A, 1995-12-08
Next: FIRST INVESTORS FUND FOR INCOME INC/NY, 497, 1995-12-08









                                                                      

                        SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C.  20549
                                 _______________

                                  SCHEDULE 14D-9

                      Solicitation/Recommendation Statement
                       Pursuant to Section 14(d)(4) of the
                         Securities Exchange Act of 1934

                                (Amendment No. 6)

                                 _______________

                               CBI INDUSTRIES, INC.
                            (Name of Subject Company)

                               CBI INDUSTRIES, INC.
                       (Name of Person(s) Filing Statement)

                     Common Stock, par value $2.50 per share
                 (and Associated Preferred Stock Purchase Rights)
                          (Title of Class of Securities)
                                 _______________

                                   124800 10 3
                      (CUSIP Number of Class of Securities)
                                 _______________

                             Charles O. Ziemer, Esq.
                    Senior Vice President and General Counsel
                               CBI Industries, Inc.
                               800 Jorie Boulevard
                         Oak Brook, Illinois  60521-2268
                                  (708) 572-7000
             (Name, Address and Telephone Number of Person Authorized
                 to Receive Notices and Communications on Behalf
                        of the Person(s) Filing Statement)
                                 _______________

                                 With a copy to:

                             Richard D. Katcher, Esq.
                          Wachtell, Lipton, Rosen & Katz
                               51 West 52nd Street
                          New York, New York  10019-6150
                                  (212) 403-1000
                                                                      <PAGE>





                   This Amendment No. 6 amends and supplements the
         Solicitation/Recomendation Statement on Schedule 14D-9 filed
         with the Securities and Exchange Commission (the "Commission")
         on November 16, 1995, and as subsequently amended (as so
         amended, the "Schedule 14D-9"), by CBI Industries, Inc., a
         Delaware corporation (the "Company" or "CBI"), relating to the
         tender offer made by PX Acquisition Corp. ("P Sub"), a Delaware
         corporation and a wholly owned subsidiary of Praxair, Inc., a
         Delaware corporation ("Praxair"), to purchase all outstanding
         shares of Common Stock, including the associated Rights issued
         pursuant to the Amendment and Restatement dated as of August 8,
         1989 of a Rights Agreement dated as of March 4, 1986, between
         the Company and First Chicago Trust Company of New York, as
         Rights Agent, at a price of $32.00 per Share, net to the seller
         in cash, upon the terms and subject to the conditions set forth
         in the Offer to Purchase dated November 3, 1995 and the related
         Letter of Transmittal (which together constitute the "Praxair
         Offer"), as disclosed in a Tender Offer Statement on Schedule
         14D-1 filed by P Sub and Praxair with the Commission on
         November 3, 1995, and as subsequently amended.  Unless
         otherwise indicated, all capitalized terms used but not defined
         herein shall have the meanings ascribed to them in the Schedule
         14D-9.


         Item 4.   The Solicitation or Recommendation.

                   (a)  On December 7, 1995 CBI sent a letter to employees 
         of the Company deemed to be CBI Salaried Employees pursuant to 
         the CBI Salaried Employee Stock Ownership Plan (1987), which letter
         is attached hereto as Exhibit 35.

         Item 9.   Material to be Filed on Exhibits

                   Item 9 is hereby amended and supplemented by adding
         thereto the following:


         Exhibit 35     Letter from the Company to CBI Salaried
                        Employees, dated December 7, 1995.<PAGE>





                                    SIGNATURE


                   After reasonable inquiry and to the best of its know-
         ledge and belief, the undersigned certifies that the informa-
         tion set forth in this statement is true, complete and correct.


                                       CBI INDUSTRIES, INC.



         Dated:  December 8, 1995      By:  /s/ John E. Jones          
                                            John E. Jones
                                            Chairman, President and
                                              Chief Executive Officer  <PAGE>





                                  EXHIBIT INDEX



         Exhibit 35     Letter from the Company to CBI Salaried
                        Employees, dated December 7, 1995.

                                                             EXHIBIT 35










                                 [CBI Letterhead]





         December 7, 1995



         To:  CBI Salaried Employees


         Over the last several weeks, you undoubtedly have seen the
         press coverage of events surrounding Praxair's proposal to
         acquire CBI Industries, Inc.  You should be aware that there
         are certain legal considerations that limit our ability to
         communicate on these matters; however, there has been a recent
         development which directly affects ESOP participants of which
         you should be aware.  The Company has been informed that on
         December 1, 1995, the ESOP Trustee, LaSalle National Trust
         N.A., made an independent decision to sell all of the ESOP's
         allocated and unallocated shares of common stock on the open
         market at a net price per share of $33.2507.  All ESOP partici-
         pants can expect a letter from the Trustee shortly regarding
         this action.  However, here is some additional information.

              -    The common shares disposed of by the ESOP constituted
                   approximately 25% of the common shares beneficially
                   owned by the ESOP.  The remaining 75% of the common
                   shares beneficially owned by the ESOP Trust continue
                   to be held by the Trustee in the form of CBI convert-
                   ible preferred stock.

              -    The ESOP will continue to operate essentially as it
                   did before this event, except that each participant's
                   account will be credited with $33.2507 in cash for
                   each share of common stock held in each participant's
                   account at the time of the sale.

              -    The Trustee advises that the sales proceeds, whether
                   allocated to participants' accounts or held as an
                   unallocated asset of the trust, will be invested in
                   short-term instruments, subject to possible reinvest-
                   ment in CBI common stock.  Participants' accounts
                   will be credited with interest earned on the cash
                   held in their accounts.

              -    The sale of the common shares by the Trustee does not
                   constitute any form of ESOP distribution or taxable
                   event to participants.<PAGE>




         December 7, 1995
         Page 2




         I would also like to use this opportunity to bring you up to
         date on other related matters.  As you know, on November 3
         Praxair initiated an unsolicited tender offer to acquire all
         outstanding common shares of CBI Industries, Inc. stock at
         $32.00 per share.  On November 16, the CBI Board of Directors
         announced that it had rejected Praxair's offer after having
         determined that the offer was inadequate, and at the same time
         the Board said that it would explore alternatives to maximize
         shareholder value.  Praxair, along with others, has signed a
         confidentiality agreement and is participating in this process,
         which continues.

         I certainly recognize that the continuing talk of change is, at
         best, unsettling.  However, we as employees are best served by
         continuing to focus on the needs of our customers, and your
         efforts in this regard are truly appreciated.  We will try to
         keep you informed of additional developments.





         /s/ John E. Jones         
         John E. Jones
         Chairman, President and
         Chief Executive Officer


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission